United Therapeutics Newsroom

Form 144 | United Therapeutics(UTHR.US) Director Proposes to Sell 3.82 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Nov 5, $United Therapeutics(UTHR.US)$ Director RICHARD GILTNER intends to sell 10,000 shares of its common stock on Nov 5, with a total market value of approximately $3.82

Moomoo NewsNov 5 16:39 ET

United Therapeutics Corporation to Present at the UBS Global Healthcare Conference

BusinesswireNov 5 16:30 ET

United Therapeutics(UTHR.US) Officer Sells US$5.5 Million in Common Stock

Moomoo NewsNov 4 16:36 ET

Mid-cap Stocks With 'Significant Scope' to Upside – WF

Seeking AlphaNov 4 15:37 ET

Form 144 | United Therapeutics(UTHR.US) Officer Proposes to Sell 5.5 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Nov 1, $United Therapeutics(UTHR.US)$ Officer MICHAEL I BENKOWITZ REVOCABLE TRUST intends to sell 14,700 shares of its common stock on Nov 1, with a total market value of

Moomoo NewsNov 1 16:28 ET

Argus Research Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $400

Moomoo NewsOct 31 10:31 ET · Ratings

United Therapeutics Is Maintained at Buy by Argus Research

Dow JonesOct 31 10:23 ET · Ratings

Jefferies Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $432

Moomoo NewsOct 31 09:40 ET · Ratings

HC Wainwright & Co. Maintains Buy on United Therapeutics, Raises Price Target to $425

BenzingaOct 31 09:34 ET · Ratings

A Quick Look at Today's Ratings for United Therapeutics(UTHR.US), With a Forecast Between $395 to $600

Moomoo NewsOct 31 09:00 ET · Ratings

Express News | United Therapeutics Corp : Leerink Partners Raises Target Price to $390 From $383

ReutersOct 31 06:31 ET

United Therapeutics | 10-Q: Q3 2024 Earnings Report

SECOct 30 06:37 ET · Announcements

Earnings Flash (UTHR) UNITED THERAPEUTICS CORPORATION Posts Q3 Revenue $748.9M

MT NewswiresOct 30 06:31 ET

United Therapeutics GAAP EPS of $6.39 Misses by $0.03, Revenue of $748.9M Beats by $26.09M

Seeking AlphaOct 30 06:30 ET

Press Release: United Therapeutics Corporation Reports Third Quarter 2024 Financial Results

Dow JonesOct 30 06:30 ET

Express News | United Therapeutics Q3 Net Income USD 309.1 Million

ReutersOct 30 06:30 ET

Express News | United Therapeutics Q3 Revenue USD 748.9 Million Vs. IBES Estimate USD 722.6 Million

ReutersOct 30 06:30 ET

Earnings Outlook For United Therapeutics

BenzingaOct 29 14:01 ET

J.P. Morgan Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $360

Moomoo NewsOct 29 06:33 ET · Ratings

Earnings Preview: UTHR to Report Financial Results Pre-market on October 30

Moomoo NewsOct 24 21:00 ET